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Abstract
Background: Antibiotic consumption is associated with adverse drug events (ADE) and increasing antibiotic resistance.
Detailed information of antibiotic prescribing in different age categories is scarce, but necessary to develop strategies for
prudent antibiotic use. The aim of this study was to determine the antibiotic prescriptions of different antibiotic classes in
general practice in relation to age.
Methodology: Retrospective study of 22 rural and urban general practices from the Dutch Registration Network Family
Practices (RNH). Antibiotic prescribing data were extracted from the RNH database from 2000–2009. Trends over time in
antibiotic prescriptions were assessed with multivariate logistic regression including interaction terms with age. Registered
ADEs as a result of antibiotic prescriptions were also analyzed.
Principal Findings: In total 658,940 patients years were analyzed. In 11.5% (n = 75,796) of the patient years at least one
antibiotic was prescribed. Antibiotic prescriptions increased for all age categories during 2000–2009, but the increase in
elderly patients (.80 years) was most prominent. In 2000 9% of the patients .80 years was prescribed at least one
antibiotic to 22% in 2009 (P,0.001). Elderly patients had more ADEs with antibiotics and co-medication was identified as
the only independent determinant for ADEs.
Conclusion/Discussion: The rate of antibiotic prescribing for patients who made a visit to the GP is increasing in the
Netherlands with the most evident increase in the elderly patients. This may lead to more ADEs, which might lead to higher
consumption of health care and more antibiotic resistance.
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Introduction
The majority of antibiotics (80%) in the Netherlands are
prescribed in primary care [1]. Outpatient antibiotic consumption
is higher in elderly patients than in the general population [2–4]
and most antibiotics are prescribed in elderly patients for
respiratory tract infections (RTI) [5], skin and soft tissue infections
[6] and urinary tract infections (UTI) [7]. However, detailed
information of antibiotic prescribing in elderly is scarce. The
majority of studies have been done in children, who also have
a high antibiotic consumption [2,8,9]. The paucity of data on
antibiotic use in elderly is surprising since elderly patients are more
susceptible to toxic effects of antibiotics. For instance, adverse drug
events (ADEs) have been described more frequently in frail elderly
with co-morbidity and co-medication [10]. Additionally, elderly
patients have altered pharmacokinetics, such as decreased
absorption and elimination, which alters antibiotic blood levels,
thereby influencing the risk of ADEs [11].
Antibiotic use is slowly, but steadily increasing in the Nether-
lands since 2005 [12]. It is unknown whether the increase in
antibiotic use is equal in all age categories. Trends over time in
antibiotic use per age category have not been studied and more
information on the highest age categories is crucial as a quarter of
the Dutch population will be above 65 years in the near future,
similar to other European countries [13].
To determine trends in antibiotic prescribing in elderly, we have
assessed antibiotic prescription rates by age categories in general
practices over a ten year period in a large general practice
database. Additionally, we have analyzed the incidence of
registered ADEs due to antibiotics.
Methods
The data for this study are obtained retrospectively from the
Dutch Registratie Netwerk Huisartsen (RNH, Registration Net-
work Family Practices). The study group is described and
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regrouped into four different age categories: 18–44 years, 45–64
years, 65–79 years and$80 years. In these age categories, we have
compared rates and trends over time in antibiotic prescriptions.
Individual prescriptions per patient in a year were used as measure
of prescriptions. For each prescription (at the moment of the
specific consultation) information on ADE (until 4 weeks after
prescription) and co-medication (at and during the prescription)
were used. Data were then aggregated over a specific patient and
calendar year to obtain a meaningful measure (% per patient-
year).
Data Source
The RNH is a continuous, computerized and anonymous
database from 22 rural and urban general practices in the south of
the Netherlands, Limburg, [14]. During the study period the
average number of patients .18 years in the RNH was 65,894
patients. The population was stable with respect to general
sociodemographic characteristics.
The GP is responsible for the inclusion of patients. When
a patient is included a unique RNH number is attributed to the
patient. The GP records patient characteristics, i.e. birthdates, sex,
educational level, insurance, type of household, marital status,
place of residence, date of entry, last update and end of
registration. The GP records all relevant health problems, only
permanent, chronic and recurrent (.3 recurrences within a period
of 6 months) are recorded, or when they had lasting consequences
for the functional status or prognosis of the patient. Medication
prescriptions (coded according to the Anatomical Therapeutic
Chemical Index 2012 by the WHO Collaborating Centre for
Drug Statistics Methodology) are included in the RNH database
Registration. This includes type of medication, start and end date,
and dose. Diagnoses are coded in a standardized fashion,
according to the International Classification of Primary Care,
using the criteria of the International Classification of Health in
Primary Care and the current guidelines of the Dutch College of
GPs [15]. Monitoring by the RNH registry ends at migration or
death. All practices use MicroHIS (Torex-Hiscom), a commercially
developed general practice health information software program
containing a basic module, a medical module and a pharmacy
module, which enable the GP to keep up an automated
registration of his patients. Quarterly the RNH data collection
module enables the GP to exchange all registered data to the
central database. The RNH assistant checks the data and the
RNH test module provides the distribution of the practice
population, e.g. tables with the age distribution and the twenty
most registered ICPC codes. The RNH exports the database in an
SPSS data format.
A number of instruments are available in order to improve the
quality and to reduce the inter-doctor variation: all GPs
participating in the RNH are instructed and trained, RNH help
program exists with all guidelines and criteria described, regional
consensus group meeting take place at least 4 times a year to discus
their registration difficulties, special software for data control in the
health information system used by the GP and, special software for
data control in the central database, several quality control
experiments have been performed to gain insight into the quality
of the database and several measures of agreement were done
[14,16].
Data Analysis
Chronic diseases are selected from the classification from
chronic diseases of Knottnerus [17]. We have included all chronic
Table 1. Population characteristics of the RNH in patient years.
Antibiotic prescription Total
No Yes
Age categories
N 18–44 yr 252,120 (43%) 28,297 (37%) 280,417 (43%)
N 45–64 yr 210,943 (36%) 26,581 (35%) 237,524 (36%)
N 65–79 yr 92,691 (16%) 15,440 (20%) 108,131 (16%)
N .80 yr 27,390 (5%) 5,478 (7%) 32,868 (5%)
Gender
N Male 289,966 (50%) 28,655 (38%) 318,621 (48%)
N Female 293,178 (50%) 47,141 (62%) 340,319 (52%)
Education
N Secondary school or lower secondary vocational education 188,361 (32%) 30,161 (40%) 218,522 (33%)
N Senior secondary vocational education 81,523 (14%) 11,905 (16%) 93,428 (14%)
N Higher education and University 26,248 (5%) 3,352 (4%) 29,600 (5%)
N Unknown 287,012 (49%) 30,378 (40%) 317,390 (48%)
Chronic disease
N No 369,062 (63%) 39,161 (52%) 408,233 (62%)
N Yes 214,082 (37%) 36,635 (48%) 250,717 (38%)
General Practice
N Rural 386,365 (66%) 45,900 (61%) 432,265 (66%)
N Urban 196,779 (34%) 29,896 (39%) 226,675 (34%)
Total 583,144 (85%) 75,796 (15%) 658,940 (100%)
doi:10.1371/journal.pone.0051860.t001
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diseases, only congenital diseases have been excluded. Using ATC
code J01 for all antibacterial medication for systemic use, further
discrimination is made for antibiotic classes used in general
practice, i.e. tetracycline (ATC J01A), penicillins (ATC J01C),
sulphonamides and trimetroprim (ATC J01E), macrolides (ATC
J01F), fluoroquinolones (ATC J01MA) and nitrofuran derivates
(ATC J01XE). Antifungals (J02) and anti-tuberculosis drug (J03)
excluded All other medication present at the moment when
antibiotics have been prescribed are considered co-medication.
Co-medication is registered in the following groups of medication:
drugs for peptic ulcer and gastro-esophageal reflux (ATC A02B),
antithrombotic agents (ATC B01A), cardiovascular medication
(ATC C), corticosteroids for systemic use (ATC H02), anti-
inflammatory and anti-rheumatic products, non-steroids anti-
inflammatory drugs (ATC M01A), other analgesics and anti-
pyretics (ATC N02B), anxiolytics (ATC N05B), hypnotics and
sedatives (ATC N05C), antidepressants (ATC N06A), and
antihistamines for systemic use (ATC R06). Since 1996 the
RNH is recording all ADEs as ICPC code A85. All kinds of ADEs
could be recorded at the discretion of the attending GP. ADEs are
considered associated with antibiotic prescription if occurring
within four weeks after start of antibiotics. The ADEs are self-
reported by patients and were recorded as an ADE at the
discretion of the attending GP.
Statistical Analysis and Ethics
Unit of analyses are patient years, where a patient contributed
one patient-year when he or she had attended a GP in that
calendar year. Outcome measures included in the analyses are:
antibiotic prescriptions (yes/no in a year), the number of antibiotic
prescriptions (cumulated within a patient over a year) and ADEs
(yes/no in a year). For antibiotic prescriptions, a multivariate
model was build including age, time, gender, education level and
rural versus and urban general practice, and chronic disease. In
analyses with ADE as outcome restricted the study population to
patient-years with antibiotic prescription and the multivariate
model included age, time, gender, education level and rural versus
and urban general practice, chronic disease and co-medication.
The variables on age and time were presented, as these were our
main focus, while controlling for the other variables. Interaction
terms between age and time were explored. Statistical analysis is
done with SPSS 16.0. A p-value ,0.05 is considered statistically
significant.
All patients included in the RNH database have been informed
about the potential anonymous use of their health information. If
a patient does not agree, the inclusion of this patient in the RNH
database is stopped. All data in this study were analyzed
anonymously, only medications and clinical data were used. The
Medical Ethics Committee of the Maastricht University Medical
Center approved this study (METC 12-4-053).
Results
A total of 658,940 patient years were analyzed from 2000–2009:
43% (n= 280,417) of the patients years were aged between 18–44
years, 36% (n= 237,524) between 45–64 years, 16% (n= 108,131)
between 65–79 years and 5.0% (n= 32,868) $80 years. Forty
eight percent (n = 318,621) of the patient years were comprised by
male and 52% (n= 340,319) were comprised by female, see
Table 1 for population characteristics of the RNH. Socio-
demographical characteristics of samples in other studies, which
made use of the RNH database, have shown to be comparable to
the Dutch population [16]. The elderly (.65 years) are slightly
Figure 1. Percentage of patients years with at least one antibiotic prescription that year in different age categories during 2000–
2009 (p,0.001).
doi:10.1371/journal.pone.0051860.g001
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overrepresented in the RNH, 22% compared to 14% in the Dutch
population in 2007. Hence, we do consider our results to be
accurate and representative for the Dutch population, with a high
internal and external generalizability.
In total 11.5% (n= 75,796) of the patient years at least one
antibiotic per year was prescribed. Antibiotics were more often
prescribed in elderly patients (p,0.001), as shown in Figure 1.
The association with higher age was present in all years studied.
Prescription rates of all antibiotics increased in all age-categories
over time (all p,0.001). Although an increase was observed in all
age categories, the increase was strongest in patients .80 years
(interaction between age and time: p,0.001). This increase is seen
Figure 2. Percentage of patients with at least one antibiotic prescription that year for different classes of antibiotic prescriptions in
different age categories during 2000–2009 (p,0.001).
doi:10.1371/journal.pone.0051860.g002
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for all antibiotic classes, with the exception of the macrolides
(Figure 2). The number of antibiotic prescriptions per patient per
year increased with age (p,0.001): two or more antibiotic courses
were prescribed for 18% (n= 1,571) of the patients years in 18–44
years, 19% (n= 5,042) in 45–64 years, 23% (n= 3,581) in 65–79
years and 29% (n= 1571) in $80 years. The number of
prescriptions independently increased with age and independently
increased over time (p,0.001).
ADEs, Underlying Diseases and co-medication
Of all patients who received an antibiotic prescription, the
minority (2%; n= 1,526/75,796) reported an ADE in the four
weeks time window. In a random sample of 4 week periods from
the same patients, compared to any 4 week period, excluding
antibiotic prescriptions during this period, rates found were 0.06%
(n= 425/658,346) without antibiotics. No time trend in ADE
reporting was observed. ADEs were not reported more frequently
in the later years (2008/2009) compared to the earlier years
(2000/2001). ADEs increased per age category per calendar year
from 1.8% in 18–44 years, 1.9% in 45–64 years and 2.3% in 65–
79 years to 2.8% in $80 years. However, co-medication also
increased per age category from 23% (n= 6,529) in 18–44 years,
49% (n= 13,078) in 45–64 years and 70% (n= 10,978) in 65–79
years to 78% (n= 4,275) in $80 years. As expected, underlying
chronic diseases increased by age. Of all patient years analyzed
18% (n= 50,924) were diagnosed with at least one chronic disease,
40% (n= 94,376) in the 45–64, 72% (n= 77,530) in 65–79 and
85% (n= 27,887) in .80 years age category. In the univariate
analysis older age, having one or more chronic disease and co-
medication were associated with occurrence of ADE. In the
multivariate analysis use of co-medication remained associated
with ADE (p,0.001) (Figure 3), while age and chronic disease
were not.
Discussion
This large primary cohort shows that the rate of antibiotic
prescribing for patients who made a visit to the GP has increased
in Dutch general practice from 2000 to 2009 in all adult age
categories. We have observed the highest increase in the rate of
antibiotic prescriptions in elderly patients; from 9% of patients
receiving at least one antibiotic in 2000 to 22% in 2009.
Additionally, elderly patients more often receive two or more
antibiotic prescriptions per patient than younger patients. We have
shown increasing trends for all antibiotic subgroups. This is
particularly striking for the fluoroquinolones, as these are not
indicated as first choice in any Dutch general practice guideline. In
the United States nonapproved fluoroquinolone prescribing has
already been described in 2005 [18]. Only the macrolides have
shown a stable prescription pattern over time and across groups.
Elderly patients have more ADEs associated with antibiotics. Co-
medication has been identified as the only independent de-
terminant for ADEs. Age was not in the multivariate analysis.
Our finding that the antibiotic prescription is increasing since
2005 in the Netherlands is comparable with the increase in Europe
as shown in the European Surveillance of Antimicrobial
Consumption data [19]. Although, the prescription rate in the
Netherlands is increasing, it is still low compared to other
European countries [19]. The Dutch guidelines for GPs of
common infections have not been changed significantly during
these ten-years. However, the increase of the number of
fluoroquinolone prescriptions suggests that guidelines are not
always followed. The increase in antibiotic prescriptions might be
explained by an increased consultation frequency for acute
infections, such as RTIs and UTIs. Although, the consultation
frequency historically has tended to decrease over the years [20], it
was recently shown that consultation rates for lower RTIs are
increasing in the Netherlands while RTI related consultations are
stable in the UK [21]. In this study however, we did not have
access to the ICPC coding for acute conditions such as acute
respiratory tract infections.
To our knowledge only three previous studies, one in England/
Wales, one in New Zealand and one in Italy, have shown higher
antibiotic consumption in elderly patients (.75 years) [2,3]. We
showed that elderly patients consistently have high antibiotic
prescription rates compared to the younger patients and there is
an increasing trend over time as well in these in elderly patients.
The highest risk group to develop ADEs is aged over 80 years
with multiple co-morbidity and co-medication [22,23]. Inappro-
priate prescriptions are a leading cause for the development of
ADEs [24,25]. Although, the observed rate of ADEs in our study is
lower than the 5–35% found in other studies [26–28] our study is
in line with studies that show that co-medication and the number
of co-medication is an independent association with ADEs due to
antibiotic use [23,29]. To prevent ADEs in elderly patients due to
antibiotic use, the necessity of antibiotic treatment needs to be
carefully determined, especially when co-medication is used.
Minimizing unnecessary antibiotic treatment by even a small
percentage could significantly reduce immediate and direct risks of
ADE in individual patients [30].
The main strengths of this study are the long study period and
the large representative study group. Since 1996 this RNH
database is keeping records of all medications (including anti-
biotics) via a computerized medical registration program. Data
accuracy can be guaranteed as data extraction takes place from
electronic medical records of practices and regular training of the
GPs and quality controls of the data take place [14,16]. All
patients with multiple antibiotic prescriptions per year have been
included only once per year. Therefore, this study group is not
biased by a few fragile elderly patients with multiple antibiotic
prescriptions.
However, this study has several limitations. Firstly, antibiotic
prescriptions could not be given in daily defined dosages (DDDs)
like some international data [31,32], limiting comparability with
other studies. Secondly, we have no diagnostic information on
acute infections. Thirdly, ADEs were self-reported by the patients,
Figure 3. Percentage of adverse drug events with number of
co-medication per age category during 2000–2009.
doi:10.1371/journal.pone.0051860.g003
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most probably underestimating the incidence of ADE associated
with antibiotics.
Based on our findings, future strategies to decrease the antibiotic
consumption and antibiotic resistance in the Netherlands should
be addressed to all adult age categories. The elderly could be
a specific target group and more in-depth study into the reasons
for increasing antibiotic prescribing is necessary.
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